Supernus Pharmaceuticals, Inc. financial statements, including revenue, expenses, and profit
The total revenue of SUPN for the last quarter is 174.16 M USD, and it's 0.87% lower compared to the previous quarter. The net income of Q4 24 is 15.33 M USD.